Video Experimental Relacionado

Updated: Sep 10, 2025

Identification of Transcription Factor Regulators using Medium-Throughput Screening of Arrayed Libraries and a Dual-Luciferase-Based Reporter

Identification of Transcription Factor Regulators using Medium-Throughput Screening of Arrayed Libraries and a Dual-Luciferase-Based Reporter

Published on: March 27, 2020

El eje YY1-EZH2-RKIP desregulado en las células cancerosas y la evasión inmune

Talia Festekdjian¹, Benjamin Bonavida¹

¹Department of Microbiology, Immunology & Molecular Genetics, David Geffen School of Medicine, Jonsson Comprehensive Cancer Center, University of California at Los Angeles, CA 90095, USA.

Biochimica et biophysica acta. Reviews on cancer

|August 23, 2025

Resumen

La resistencia a la inmunoterapia del cáncer puede superarse apuntando al eje YY1-EZH2-RKIP. Este eje regula la evasión inmune, y su inhibición puede restaurar las respuestas antitumorales en pacientes que no responden.

Área de la Ciencia:

En el campo de la oncología
Inmunología
Biología molecular

Sus antecedentes:

La inmunoterapia ha demostrado ser prometedora en el tratamiento del cáncer, pero un subconjunto de pacientes sigue sin responder debido a la evasión inmune.
La identificación de los mecanismos moleculares de evasión inmune es crucial para el desarrollo de nuevas terapias dirigidas para mejorar la eficacia de la inmunoterapia.

Objetivo del estudio:

Caracterizar las funciones de Yin Yang1 (YY1), EZH2 y RKIP (PEBP1) en la evasión inmune del cáncer.
Aclarar las funciones reguladoras moleculares y las vías de señalización involucradas en la desregulación de YY1, EZH2 y RKIP.
Establecer el eje YY1-EZH2-RKIP como un objetivo terapéutico potencial para superar la resistencia a la inmunoterapia.

Principales métodos:

Análisis de las funciones de regulación molecular y las vías de señalización.
Caracterización de la desregulación del producto génico (sobreexpresión / subexpresión).
Identificación de las vías de señalización de intercambio entre YY1, EZH2 y RKIP.

Principales resultados:

Identificó YY1, EZH2 y RKIP como productos genéticos clave en la evasión inmune.
Se describen las vías moleculares que conducen a la sobreexpresión de YY1 y EZH2 y a la subexpresión de RKIP.
Estableció el eje YY1-EZH2-RKIP desregulado y su papel en la regulación de la evasión inmune.

Conclusiones:

El eje YY1-EZH2-RKIP es un nuevo objetivo terapéutico para inhibir la evasión inmune en el cáncer.
Dirigirse a este eje inhibiendo YY1 o EZH2, o induciendo RKIP, puede restaurar la inmunoterapia antitumoral.
Se justifica una mayor investigación preclínica de los agentes dirigidos a este eje, con un enfoque en la administración específica del tumor.

Palabras clave:

El cáncer Las conversaciones cruzadas En el caso de los Evasión inmune RKIP (en inglés)Orientación terapéutica YY1 (en inglés)

Más Videos Relacionados

Combined Use of Tail Vein Metastasis Assays and Real-Time In Vivo Imaging to Quantify Breast Cancer Metastatic Colonization and Burden in the Lungs

Combined Use of Tail Vein Metastasis Assays and Real-Time In Vivo Imaging to Quantify Breast Cancer Metastatic Colonization and Burden in the Lungs

Published on: December 19, 2019

All-optical Mechanobiology Interrogation of Yes-associated Protein in Human Cancer and Normal Cells using a Multi-functional System

All-optical Mechanobiology Interrogation of Yes-associated Protein in Human Cancer and Normal Cells using a Multi-functional System

Published on: December 20, 2021

Videos de Conceptos Relacionados

Induced Pluripotent Stem Cells

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...

Abnormal Proliferation

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...

Adaptive Mechanisms in Cancer Cells

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...

Epigenetic Regulation

Epigenetic Regulation

Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...

mTOR Signaling and Cancer Progression

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...

Mechanisms of Retrovirus-induced Cancers

Mechanisms of Retrovirus-induced Cancers

Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...